The label states that the majority of reports of nausea, vomiting and diarrhea occurred during dose escalation, which indicates these reactions cluster around increases rather than persisting throughout treatment
From digestion and immune health to weight regulation and mood, your gut microbiome plays a massive role in how you feel and function every day
Those who stop GLP-1 therapy may also gain more weight during pregnancy compared to those who were never on treatment
In response, pharma manufacturers are significantly increasing manufacturing capacity to produce these sensitive drugsa complex undertaking
FDA Fast Track designation for tirzepatide for the treatment of adults with obesity, or overweight with weight-related comorbidities. GLP duration in the body: Frontiers in Endocrinology (2019)
When to Expect Visible Results Based on the clinical trial data and the broader GLP-1 receptor agonist class experience, the following general timeline can be outlined